This study is comparing a new dressing, Altrazeal® Transforming Powder Dressing, to the usual care for pressure injuries (also called pressure ulcers). Pressure injuries are wounds that can range from mild to very deep. This study is for people with Stage 2, 3, or 4 pressure injuries. Researchers want to see if Altrazeal® can reduce how often dressings need to be changed over 12 weeks. They will also look at how well wounds heal, pain, quality of life, and costs. The study aims to enroll 300 participants, but its current recruitment status is unclear.

Study design

This study will involve about 300 participants who will be randomly assigned to receive either Altrazeal® or standard care. This is an interventional study, meaning participants will receive a specific treatment.

What's involved

If you join, your pressure injury wounds will be cleaned, photographed, and measured at each study visit. A dressing will then be applied according to your assigned study group.

Compensation

Not stated in the trial record.

Follow-up

The primary goal of the study is measured at 12 weeks, focusing on the number of wound dressing changes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.